RecruitingPhase 2NCT03866382
Endocrine
Medullary thyroid carcinoma
16
studies recruiting now
as of 7 Sept 2026
187
studies registered in total
as of 7 Sept 2026
2
countries with a recruiting site
as of 7 Sept 2026
7 Feb 2025
most recent study posted
among recruiting studies
Recruiting trials
RecruitingNCT01109420
Clinical and Genetic Studies in Familial Non-medullary Thyroid Cancer
RecruitingNCT01660984
Natural History Study of Children and Adults With Medullary Thyroid Cancer
RecruitingPhase 2NCT06161532
Sacituzumab Govitecan With or Without Atezolizumab Immunotherapy in Rare Genitourinary Tumors (SMART) Such as High Grade Neuroendocrine Carcinomas, Adenocarcinoma, and Squamous Cell Bladder/Urinary Tract Cancer, Renal Medullary Carcinoma and Penile C...
RecruitingPhase 1 / Phase 2NCT06814496
Radiation Combined With BIspecific T-Cell Engager in DLL3 Expressing Tumors
Showing the 5 most recently updated recruiting studies, as recorded 7 Sept 2026. Live status on each study page.
See all 16 recruiting studiesWhere recruiting studies are running
Countries with at least one recruiting site among the studies above, 7 Sept 2026. Tap a country to search trials there.
Keep watching
Get an email when a new Medullary thyroid carcinoma study opens.
One email a day at most. Unsubscribe with one click.
Used only for these alerts. Privacy.
Support
Patient organisations
We do not yet list a dedicated organisation for this condition. The directories below are the best route.
About Medullary thyroid carcinoma
RareTrial does not yet hold a plain-language description of this condition. The most reliable starting point is Orphanet’s expert page, which lists specialist centres, registries and patient organisations.
Treatments being studied
4 approved treatments and 15 in clinical development, from Open Targets (CC BY 4.0). Not medical advice.
Approved: CabozantinibApproved: Vandetanib (Caprelsa)Approved: Pralsetinib (Gavreto)Approved: Selpercatinib (Retevmo)
Phase 2/3Catequentinib
Phase 2Sorafenib
Phase 2Ponatinib (Iclusig)
Phase 2Pasireotide (Signifor)
Phase 2Pembrolizumab (Keytruda)
Phase 2Everolimus (Afinitor)
Phase 2Vorinostat (Zolinza)
Phase 2Lithium Carbonate (Camcolit 250)
+ 7 more in development
Related conditions
Information, not medical advice. Trial listings are shown as recorded on ClinicalTrials.gov; whether any study is right for you is a decision for you and your clinicians, and eligibility is decided by each research team. Disease information from Orphanet (CC BY 4.0).